Literature DB >> 25862878

Nephroprotective effects of hydration with magnesium in patients with cervical cancer receiving cisplatin.

Yoshihiro Yamamoto1, Kazushi Watanabe2, Ikuto Tsukiyama3, Hiroshi Matsushita2, Hiromitsu Yabushita2, Katsuhiko Matsuura3, Akihiko Wakatsuki2.   

Abstract

AIM: The present study aimed to assess the efficacy of 15 mEq magnesium supplied as part of a prehydration regimen in preventing cisplatin-induced nephrotoxicity in patients undergoing therapy with cisplatin-alone (40 mg/m(2)/week) for cervical cancer. PATIENTS AND METHODS: We studied 28 patients with cervical cancer. This prospective cohort study compared nephrotoxicity in patients who received hydration with and without magnesium sulfate (Mg-hydration group, n=14; non-Mg-hydration group, n=14).
RESULTS: Baseline characteristics, stage of cervical cancer, cisplatin dose and renal function did not differ significantly between the two groups. The serum creatinine level significantly increased from 0.58 to 0.75 mg/dl, and the estimated glomerular filtration rate significantly decreased from 85.1 to 66.5 ml/min by chemotherapy in the non-Mg-hydration group. In contrast, these levels did not change significantly in the Mg-hydration group.
CONCLUSION: A magnesium dose of 15 mEq was found to provide nephroprotective effects among patients with cervical cancer undergoing chemotherapy with cisplatin alone. Copyright
© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  cervical cancer; cisplatin; hydration; magnesium; nephrotoxicity

Mesh:

Substances:

Year:  2015        PMID: 25862878

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

1.  Prevention of Cisplatin-Induced Acute Kidney Injury: A Systematic Review and Meta-Analysis.

Authors:  Aghilès Hamroun; Rémi Lenain; Jean Joel Bigna; Elodie Speyer; Linh Bui; Paul Chamley; Nicolas Pottier; Christelle Cauffiez; Edmone Dewaeles; Xavier Dhalluin; Arnaud Scherpereel; Marc Hazzan; Mehdi Maanaoui; François Glowacki
Journal:  Drugs       Date:  2019-09       Impact factor: 9.546

2.  Protection of kidneys by magnesium in cisplatin chemotherapy: a fight between two metals.

Authors:  Fanghua Li; Man J Livingston; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2017-06-21

3.  Intravenous magnesium sulfate for prevention of vancomycin plus piperacillin-tazobactam induced acute kidney injury in critically ill patients: An open-label, placebo-controlled, randomized clinical trial.

Authors:  Hossein Khalili; Hamid Rahmani; Mostafa Mohammadi; Mohamadreza Salehi; Zahra Mostafavi
Journal:  Daru       Date:  2021-08-31       Impact factor: 4.088

Review 4.  Cisplatin nephrotoxicity: new insights and therapeutic implications.

Authors:  Chengyuan Tang; Man J Livingston; Robert Safirstein; Zheng Dong
Journal:  Nat Rev Nephrol       Date:  2022-10-13       Impact factor: 42.439

5.  Analysis of Risk Factors for High-dose Cisplatin-induced Renal Impairment in Head and Neck Cancer Patients.

Authors:  Hiroyoshi Koide; Satoshi Noda; Yumi Okunuki; Shigehiro Owaki; Takeshi Shimizu; Tomohiro Terada; Shin-Ya Morita
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

6.  Evaluation of the Effectiveness of N-Acetylcysteine in the Prevention of Colistin-Induced Nephrotoxicity: A Randomized Controlled Clinical Trial.

Authors:  Sedigheh Mosayebi; Rasool Soltani; Fatemeh Shafiee; Samane Assarzadeh; Atousa Hakamifard
Journal:  J Res Pharm Pract       Date:  2022-05-25

Review 7.  A Systematic Review of Strategies to Prevent Cisplatin-Induced Nephrotoxicity.

Authors:  Daniel J Crona; Aimee Faso; Tomohiro F Nishijima; Kathleen A McGraw; Matthew D Galsky; Matthew I Milowsky
Journal:  Oncologist       Date:  2017-04-24

Review 8.  Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity.

Authors:  Vladislav Volarevic; Bojana Djokovic; Marina Gazdic Jankovic; C Randall Harrell; Crissy Fellabaum; Valentin Djonov; Nebojsa Arsenijevic
Journal:  J Biomed Sci       Date:  2019-03-13       Impact factor: 8.410

Review 9.  Cisplatin chemotherapy and renal function.

Authors:  Jie Zhang; Zhi-Wei Ye; Kenneth D Tew; Danyelle M Townsend
Journal:  Adv Cancer Res       Date:  2021-04-28       Impact factor: 6.242

10.  Improvement of cisplatin-related renal dysfunction by synthetic ghrelin: a prospective randomised phase II trial.

Authors:  Yoshitomo Yanagimoto; Shuji Takiguchi; Yasuhiro Miyazaki; Tomoki Makino; Tsuyoshi Takahashi; Yukinori Kurokawa; Makoto Yamasaki; Hiroshi Miyata; Kiyokazu Nakajima; Hiroshi Hosoda; Kenji Kangawa; Masaki Mori; Yuichiro Doki
Journal:  Br J Cancer       Date:  2016-06-02       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.